Revvity, Inc. (RVTY)
NYSE: RVTY · IEX Real-Time Price · USD
101.51
-0.58 (-0.57%)
At close: Apr 26, 2024, 4:00 PM
101.72
+0.21 (0.21%)
After-hours: Apr 26, 2024, 7:52 PM EDT
Revvity Employees
Revvity had 11,500 employees on December 31, 2023. The number of employees decreased by 5,200 or -31.14% compared to the previous year.
Employees
11,500
Change (1Y)
-5,200
Growth (1Y)
-31.14%
Revenue / Employee
$239,180
Profits / Employee
$60,269
Market Cap
12.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
Dec 31, 2022 | 16,700 | 0 | - |
Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
Dec 31, 2019 | 13,000 | 500 | 4.00% |
Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
Dec 31, 2016 | 8,000 | 0 | - |
Dec 31, 2015 | 8,000 | 300 | 3.90% |
Dec 31, 2014 | 7,700 | 100 | 1.32% |
Dec 31, 2013 | 7,600 | 100 | 1.33% |
Dec 31, 2012 | 7,500 | 300 | 4.17% |
Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
Dec 31, 2009 | 8,200 | 300 | 3.80% |
Dec 31, 2008 | 7,900 | -800 | -9.20% |
Dec 31, 2007 | 8,700 | 200 | 2.35% |
Dec 31, 2006 | 8,500 | 500 | 6.25% |
Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
Dec 31, 2004 | 10,000 | 0 | - |
Dec 31, 2003 | 10,000 | -700 | -6.54% |
Dec 31, 2002 | 10,700 | -100 | -0.93% |
Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
Dec 31, 2000 | 12,500 | 500 | 4.17% |
Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
Dec 31, 1996 | 15,000 | 0 | - |
Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
Dec 31, 1993 | 32,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Walgreens Boots Alliance | 331,000 |
Quest Diagnostics | 48,000 |
Viatris | 38,000 |
Teva Pharmaceutical | 37,851 |
Dr. Reddy's Laboratories | 25,863 |
Medpace Holdings | 5,900 |
ShockWave Medical | 1,468 |
Neurocrine Biosciences | 1,400 |
RVTY News
- 2 days ago - Revvity Board Declares Quarterly Dividend - Business Wire
- 2 days ago - Revvity to Present at BofA Securities 2024 Health Care Conference - Business Wire
- 3 days ago - Revvity Unveils a New Era of Automated Tuberculosis Testing - Business Wire
- 12 days ago - Revvity Signals Software's New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners - Business Wire
- 23 days ago - Revvity To Hold Earnings Call on Monday, April 29, 2024 - Business Wire
- 25 days ago - Preliminary Injunction Granted to Enforce Revvity's Rights and Cloud Software Group's Obligations Related to Spotfire Software - Business Wire
- 5 weeks ago - Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group - Business Wire
- 5 weeks ago - Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication - Business Wire